Israel - English - Ministry of Health

bayer israel ltd - acetylsalicylic acid; ascorbic acid - tablets effervescent - acetylsalicylic acid 400 mg; ascorbic acid 240 mg - acetylsalicylic acid - acetylsalicylic acid - pain relief, fever reduction, antirheumatic treatment.

Malta - English - Medicines Authority

bayer s.p.a. viale certosa, 130 - 20156, milano, italy - ascorbic acid, acetylsalicylic acid - effervescent tablet - ascorbic acid 240 mg acetylsalicylic acid 400 mg - analgesics

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - vitamin d3; alendronic acid - tablet - 70 mg/5600 international unit(s) - alendronic acid and colecalciferol

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - zoledronic acid monohydrate -

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - alendronic acid; vitamin d3 - tablet - 70 mg/2800 international unit(s) - alendronic acid and colecalciferol

Ireland - English - HPRA (Health Products Regulatory Authority)

new haven pharma (uk) limited - acetylsalicylic acid - prolonged-release capsule, hard - 162.5 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid

Malta - English - Medicines Authority

wockhardt uk limited - acetylsalicylic acid - gastro-resistant tablet - acetylsalicylic acid 75 mg - antithrombotic agents

European Union - English - EMA (European Medicines Agency)

sandoz gmbh - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases, bisphosphonates - ibandronic acid sandoz is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.,

European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone; osteoporosis, postmenopausal - drugs for treatment of bone diseases - ibandronic acid 50mgibandronic acid teva is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.ibandronic acid 150mgtreatment of osteoporosis in postmenopausal women at increased risk of fracture. a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - acetylsalicylic acid - gastro-resistant tablet - acetylsalicylic acid 75 mg - antithrombotic agents